You are viewing: Spain Elastomeric Infusion Pumps Market analysis

The Spain Elastomeric Infusion Pumps Market was valued at $18.1 Million in 2025 and projected to reach to $22.3 Million by 2030, representing a compound annual growth rate of 4.3%. Spain's elastomeric infusion pumps market is positioned for steady growth through 2030, driven by the country's aging population and increasing prevalence of chronic conditions requiring continuous drug delivery.

Spain Elastomeric Infusion Pumps Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Spain Elastomeric Infusion Pumps Market Trends and Insights

  • Spain's market expansion is driven by increasing adoption of portable drug delivery systems in hospitals and home healthcare settings, supported by favorable reimbursement policies and rising prevalence of chronic diseases requiring continuous infusion therapy.
  • The Spanish healthcare sector's modernization and investment in advanced medical devices are key factors propelling demand for elastomeric infusion pumps across oncology, pain management, and antibiotic therapy applications. Spain's elastomeric infusion pumps market benefits from a well-established pharmaceutical infrastructure and growing patient preference for patient-centric, non-invasive delivery mechanisms.
  • Between 2025 and 2030, Spain is expected to see increased market penetration in both institutional and outpatient care environments.
  • The competitive landscape in Spain remains dynamic, with both multinational device manufacturers and regional players strengthening their presence to capture growing demand in this specialized medical device segment..

Key Market Statistics

  • CAGR (2025-2030) 4.3% CAGR
  • Market Size, 2025 ~USD 18.1 Million
  • Forecast, 2030 ~USD 22.3 Million
  • Country Spain

Spain Elastomeric Infusion Pumps Market Overview

Market Valuation :

Spain's elastomeric infusion pumps market is valued at USD 18.1 million in 2025, with projected growth to USD 22.3 million by 2030, reflecting steady market expansion in Southern Europe.

Growth Rate :

The Spanish market is growing at a CAGR of 4.3% through 2030, slightly below the global average of 5.3%, indicating moderate but consistent demand for elastomeric delivery systems.

Healthcare Adoption :

Increasing adoption of portable drug delivery systems in Spanish hospitals and home healthcare settings is driving market growth, supported by favorable reimbursement policies and healthcare infrastructure improvements.

Clinical Drivers :

Rising prevalence of chronic diseases and cancer treatments in Spain is accelerating demand for elastomeric infusion pumps as preferred alternatives to traditional IV administration methods.

Spain Elastomeric Infusion Pumps Market Dynamics

  • The Spanish healthcare system's emphasis on cost-effective, patient-centric solutions supports the adoption of elastomeric pumps in both hospital and home care environments.
  • Favorable reimbursement policies and growing awareness among healthcare professionals are expected to sustain market expansion.
  • However, competition from alternative delivery systems and regulatory compliance requirements may moderate growth rates compared to other European markets..

Related Ecosystem

Key Takeaways

  • Spain's elastomeric infusion pumps market is valued at USD 18.1 million in 2025 and will reach USD 22.3 million by 2030.
  • Spain's market is growing at a CAGR of 4.3%, driven by increased adoption in home healthcare and hospital settings.
  • Spain's healthcare modernization and chronic disease prevalence are key growth catalysts for elastomeric infusion pump demand.
  • Spain's market shows strong potential for both multinational and regional device manufacturers through 2030.

Elastomeric Infusion Pumps Market Report Scope

Report Metric Details
Base Year 2025
Fastest Growing Segment HOME CARE SETTINGS (Setting)
Forecast Period 2025–2030
Growth Rate CAGR of 5.3% from 2025 to 2030
Largest Segment ACCESSORIES AND CONSUMABLES (Product)
Market Size Base Year (Billions) ~USD 1.15 (2025)
Revenue Forecast (Billions) ~USD 1.49 (2030)
Segments Covered Type, Application, End-Use Industry, Product, Setting

Spain Elastomeric Infusion Pumps Market Report Segmentation

5 segment dimensions are covered across the global market.

By Type

  • Continuous Rate
  • Variable Rate

By Application

  • Analgesia/Pain Management
  • Antibiotics
  • Chemotherapy
  • Chemotherapy/Oncology
  • Diabetes Management
  • Gastroenterology
  • Hematology
  • Other Applications
  • Pain Management
  • Pediatrics/Neonatology

By End-Use Industry

  • Ambulatory Surgical Centers (Ascs)
  • Homecare Settings
  • Hospitals
  • Other End-Use Industries

By Product

  • Accessories And Consumables
  • Devices

By Setting

  • Academic And Research Institutes
  • Ambulatory Care Settings
  • Home Care Settings
  • Hospitals

SPAIN: ELASTOMERIC INFUSION PUMPS MARKET, BY END-USE INDUSTRY, 2023–2030

Segment20232024202520262027202820292030CAGR (%)
AMBULATORY SURGICAL CENTERS (ASCS)4.364.54.74.95.115.335.565.794.3
HOMECARE SETTINGS4.094.244.454.664.885.125.365.624.8
HOSPITALS7.517.748.068.398.739.089.459.844.1
OTHER END-USE INDUSTRIES0.810.830.860.90.930.9611.043.8
TOTAL16.7617.3218.0618.8419.6520.4921.3722.294.3

Target Audience

  • Medical Device Manufacturers : Manufacturers need Spain-specific market data to assess market size, growth potential, and competitive positioning for elastomeric infusion pump product launches and expansion strategies.
  • Healthcare Providers & Hospitals : Spanish hospitals and healthcare systems require market insights to understand procurement trends, reimbursement policies, and adoption rates for elastomeric pumps in clinical settings.
  • Pharmaceutical Companies : Pharma firms need Spain market intelligence to evaluate drug delivery system adoption, patient preferences, and market opportunities for their injectable drug formulations.
  • Investment & Private Equity Firms : Investors targeting Spain's healthcare sector need detailed market analysis, growth forecasts, and competitive landscape data to identify acquisition and investment opportunities.
  • Healthcare Consultants & Analysts : Consultants advising Spanish healthcare organizations require country-specific market data, trend analysis, and forecasts to support strategic planning and market recommendations.

Key Companies in the Spain Elastomeric Infusion Pumps Market

CompanyHQOwnershipStrongest segments
BAXTERUnited StatesPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
NIPROJapanPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
AVNSUnited StatesPrivate CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
WOOYOUNG MEDICAL CO., LTD.South KoreaPrivate CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Electronic Infusion Pumps (adjacent),
SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.ChinaPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Accessories & Disposables for Elastomeric Pumps,
AMBU A/SDenmarkPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate Elastomeric Pumps,Chemotherapy Applications,
DAIKEN MEDICAL CO., LTD.JapanPublic CompanyContinuous Rate Elastomeric Pumps,Variable Rate / PCA Elastomeric Pumps,Chemotherapy Applications,

BAXTER

Baxter is a publicly traded American healthcare company founded in 1931 that employs 37,500 people. The company operates in the medical devices and pharmaceuticals sector.

NIPRO

Nipro is a Japanese public company founded in 1947 with 38,593 employees operating in the medical devices sector. The company serves global healthcare markets.

AVNS

AVNS is a privately held American company founded in 2014 with 2,287 employees. The company operates in the medical devices industry.

WOOYOUNG MEDICAL CO., LTD.

Wooyoung Medical Co., Ltd. is a privately held South Korean company founded in 1996. The company operates in the medical devices sector.

SHANGHAI INT MEDICAL INSTRUMENTS CO., LTD.

Shanghai Int Medical Instruments Co., Ltd. is a publicly traded Chinese medical device company founded in 2006 with 2,088 employees. The company serves the healthcare market.

AMBU A/S

Ambu A/S is a publicly traded Danish medical device company founded in 1937 with 5,200 employees. The company specializes in emergency and surgical equipment.

DAIKEN MEDICAL CO., LTD.

Daiken Medical Co., Ltd. is a publicly traded Japanese medical device company founded in 1968 with 185 employees. The company serves the healthcare industry.

Reasons to Buy this Report

  • Spain-Specific Market Sizing : Obtain precise market valuation data for Spain (USD 18.1M in 2025) with detailed forecasts through 2030, enabling accurate business planning and investment decisions for the Spanish market.
  • Competitive Landscape Intelligence : Understand Spain's unique competitive dynamics, reimbursement environment, and regulatory framework specific to elastomeric infusion pumps, differentiating it from broader European market trends.
  • Growth Driver Analysis : Identify Spain-specific growth catalysts including healthcare policy changes, aging demographics, chronic disease prevalence, and home healthcare expansion driving the 4.3% CAGR.
  • Strategic Market Entry : Develop targeted go-to-market strategies for Spain with insights into hospital adoption rates, reimbursement policies, and healthcare provider preferences specific to the Spanish market.
  • Investment Decision Support : Make informed investment and partnership decisions in Spain's elastomeric pump sector with comprehensive market data, growth projections, and regional opportunity assessment.

Frequently asked questions

What is the current market size of elastomeric infusion pumps in Spain?

Spain's elastomeric infusion pumps market is valued at USD 18.1 million in 2025.

What is the projected market size for elastomeric infusion pumps in Spain by 2030?

Spain's elastomeric infusion pumps market is projected to reach USD 22.3 million by 2030.

What is the CAGR for elastomeric infusion pumps in Spain?

Spain's elastomeric infusion pumps market is growing at a CAGR of 4.3% from 2025 to 2030.

What are the primary drivers of growth in Spain's elastomeric infusion pumps market?

Spain's market growth is driven by increased adoption in home healthcare, rising chronic disease prevalence, favorable reimbursement policies, and healthcare sector modernization.

Which applications dominate Spain's elastomeric infusion pumps market?

Spain's elastomeric infusion pumps are primarily used in oncology, pain management, and antibiotic therapy applications.

RESEARCH METHODOLOGY

The study involved four major activities to estimate the current size of the global elastomeric infusion pumps market. Exhaustive secondary research was conducted to gather information on the market, the peer product market, and the parent product group market. The next step was to validate these findings, assumptions, and sizes with the industry experts across the value chain of elastomeric infusion pumps through primary research. The top-down and bottom-up approaches were employed to estimate the overall size of the elastomeric infusion pumps market. After that, market breakdown and data triangulation procedures were used to determine the size of different segments and sub-segments of the market.

Secondary Research

The market for companies offering elastomeric infusion pumps is determined by secondary data obtained from paid and unpaid sources, analyzing the product portfolios of major companies in the ecosystem, and evaluating companies based on their performance and quality. Various secondary sources, including Business Standard, Bloomberg, the World Bank, and Factiva, were consulted to identify and collect information for this study on the elastomeric infusion pumps market. During the secondary research process, various secondary sources were consulted to identify and collect information relevant to the study. Secondary sources included annual reports, press releases, investor presentations of door vendors, forums, certified publications, and white papers. The secondary research was utilized to gather critical information on the industry’s value chain, the total pool of key players, market classification, and segmentation from both market- and technology-oriented perspectives.

Primary Research

In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side included industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), marketing directors, technology and innovation directors, and related key executives from several key companies and organizations operating in the elastomeric infusion pump market. After completing the market engineering process (calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers derived. Primary research was also conducted to identify the segmentation types, industry trends, competitive landscape of elastomeric infusion pumps offered by various market players, and key market dynamics, such as drivers, restraints, opportunities, challenges, industry trends, and key player strategies. In the complete market engineering process, the top-down and bottom-up approaches and several data triangulation methods were extensively used to perform the market estimation and market forecasting for the overall market segments and subsegments listed in this report. Extensive qualitative and quantitative analysis was performed on the complete market engineering process to list the key information/insights throughout the report.

The following is the breakdown of primary respondents:

Elastomeric Infusion Pumps Market

Notes: Other designations include sales, marketing, and product managers. Tier 1: >USD 1 Billion; Tier 2: USD 500 million–1 Billion; and Tier 3: < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The top-down and bottom-up approaches were employed to estimate and validate the size of the global elastomeric infusion pumps market. These methods were also widely used to assess the size of various related market segments. The research methodology used to determine the market size included the following:

Elastomeric Infusion Pumps Market

Data Triangulation

After determining the overall market size using market size estimation processes, the market was segmented into several segments and subsegments. The data triangulation and market breakup procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Elastomeric infusion pumps are portable, non-electronic medical devices designed for the controlled delivery of drugs, such as analgesics, antibiotics, and chemotherapeutic agents, over a specified period. These devices utilize the elastic properties of specific elastomers to deliver accurate, continuous, or intermittent medication infusions without requiring batteries or external power sources. Elastomeric infusion pumps are recognized for their simplicity, reliability, and ease of use, making them suitable for use in hospital, outpatient, and home care environments. They are produced and tested in accordance with international medical device standards, including ISO 13485 for quality management, ISO 11608 for infusion device efficacy, and ASTM standards for elastomeric materials. The devices are extensively utilized in oncology, pain management, anesthesia, and palliative care, enhancing patient compliance, mobility, and safety. Elastomeric infusion pumps are crucial to the advancement of the field of patient-centered drug delivery and healthcare innovation, particularly in home healthcare and ambulatory care.

Stakeholders

  • Elastomeric infusion pump manufacturers
  • Raw material suppliers
  • Converters & processors
  • Distributors and traders
  • Industry associations and regulatory bodies
  • End users

Report Objectives

  • To define, describe, and forecast the size of the global elastomeric infusion pumps market, based on type, end-use industry, and region in terms of value and volume
  • To provide detailed information on the significant drivers, restraints, opportunities, and challenges influencing the market
  • To strategically analyze micromarkets concerning individual growth trends, prospects, and their contribution to the market
  • To assess the growth opportunities in the market for stakeholders and provide details on the competitive landscape for market leaders
  • To forecast the market size of segments and subsegments for North America, Europe, Asia Pacific, South America, and the Middle East & Africa
  • To strategically profile key players and comprehensively analyze their market shares and core competencies
  • To analyze competitive developments such as acquisitions, expansions, partnerships, and agreements in the elastomeric infusion pumps market
  • To provide the impact of AI/Gen AI on the market

Get the Full Elastomeric Infusion Pumps Market Report

Full forecast, segment splits, and company analysis for all Elastomeric Infusion Pumps Market.

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report
Fact checked
DMCA.com Protection Status